Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

Objective Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse. Design Pharmacoepidemiological cohort study. Methods/settings From nationwide registers, we identified patients wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ open 2013-01, Vol.3 (5), p.e002758
Hauptverfasser:	Sørensen, Rikke, Gislason, Gunnar, Torp-Pedersen, Christian, Olesen, Jonas Bjerring, Fosbøl, Emil L, Hvidtfeldt, Morten W, Karasoy, Deniz, Lamberts, Morten, Charlot, Mette, Køber, Lars, Weeke, Peter, Lip, Gregory Y H, Hansen, Morten Lock
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Anticoagulants Cardiac arrhythmia Cardiology Cardiovascular disease Cardiovascular Medicine Diabetes Drug dosages FDA approval Heart failure Hypertension Ischemia Patients Pharmacy Prescription drugs Stroke Thromboembolism Transient ischemic attack
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!